Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Ceapro Inc V.CZO

Ceapro Inc. is a Canada-based biotechnology company. The Company is involved in the development of extraction technology and the application of this technology to the production of extracts and active ingredients from oats and other renewable plant resources. Its primary business activities relate to the development and commercialization of natural products for personal care, cosmetic, human, and animal health industries using technology, natural, renewable resources, and developing products, technologies, and delivery systems. The Company's products include a commercial line of natural active ingredients, including beta glucan, avenanthramides (colloidal oat extract), oat powder, oat oil, oat peptides, and lupin peptides, a commercial line of natural anti-aging skincare products, utilizing active ingredients, including beta glucan and avenanthramides and veterinary therapeutic products, including an oat shampoo, an ear cleanser, and a dermal complex/conditioner.


TSXV:CZO - Post by User

Comment by prophetoffactzon Nov 29, 2023 5:28pm
59 Views
Post# 35759728

RE:RE:RE:RE:RE:RE:Failure, again.

RE:RE:RE:RE:RE:RE:Failure, again.
Tencents wrote: Indeed - true about Avalyn
but note it took 13 years to get there and they have about 6 candidates in this area 
Still have years to go to get a product in the market 


CZO's market cap is only C$20 million. Avalyn raised C$80 million going into its Phase I. What do you think Avalyn's market cap was going into Phase I given it raised C$80 million cash going into Phase I. CZO appears a short toxicology study away from declaring a Phase I clinical trial. CZO's drug also has the COVID opportunity which Avalyn didn't have when it raised C$80 million. CZO's drug could be used beyond lung fibrosis. 40% of deaths worldwide involve fibrosis Dr. Ask noted. CZO's carrier could also be used for other drugs beyond fibrosis such as for delivering an epilepsy drug Gilles once noted. With a $20 million market cap we may not have to wait long for a payout with the stock; certainly not 13 years. Given the applications for COVID CZO could even find an accelerated path to approval. 

<< Previous
Bullboard Posts
Next >>